ロード中...
Systemic complications of the bidirectional intraoperative chemotherapy with intravenous ifosfamide and hyperthermic intraperitoneal chemotherapy (HIPEC) using cisplatin plus doxorubicin
BACKGROUND: Ifosfamide has recently used as the intravenous component of bidirectional intraoperative chemotherapy (BDIC) with hyperthermic intraperitoneal chemotherapy (HIPEC) using cisplatin plus doxorubicin. Little is known about the systemic toxicities of this BDIC regimen. Therefore, this study...
保存先:
| 出版年: | Pleura Peritoneum |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
De Gruyter
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6881663/ https://ncbi.nlm.nih.gov/pubmed/31799375 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/pp-2019-0025 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|